Ameliorating cyclosporine nephrotoxicity with intravenous protective agents.
D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000037:antagonists & inhibitors* / Q000097:blood; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000494:pharmacology; D007511:Ischemia / Q000150:complications; D007668:Kidney / Q000098:blood supply / Q000502:physiology; D007674:Kidney Diseases / Q000209:etiology* / Q000473:pathology; D008353:Mannitol / Q000494:pharmacology; D008854:Microscopy, Electron; D011817:Rabbits
D003524:Cyclosporins; D008353:Mannitol; D000493:Allopurinol; D003404:Creatinine; D011464:Epoprostenol